-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics warrants set to be delisted from Nasdaq upon expiration

PUBT·09/16/2026 20:07:21
Listen to the news
Pasithea Therapeutics warrants set to be delisted from Nasdaq upon expiration
  • Pasithea Therapeutics’ Nasdaq-listed warrants (KTTAW) will expire on Sept. 17, 2026.
  • Unexercised warrants will become void at expiration.
  • Trading in KTTAW will end on Nasdaq, followed by a Form 25 filing to delist the warrants.
  • Common stock will continue trading on Nasdaq under the symbol KTTA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-100515), on September 16, 2026, and is solely responsible for the information contained therein.